Dr. Yasmin Hamzavi Abedi, MD

Dr. Hamzavi Abedi practices at Potomac Ambulatory Surgery Center in Fairfax, Virginia.

Dr. Hamzavi Abedi's NPI, 1750648580, was assigned on April 18, 2012. Dr. Hamzavi Abedi holds Virginia license 0101282549.

Dr. Hamzavi Abedi's primary practice is Potomac Ambulatory Surgery Center, at 8503 Arlington Blvd, Fairfax, VA 22031 in Fairfax County. The practice phone is (703) 204-0000.

Dr. Hamzavi Abedi's primary practice is Potomac Ambulatory Surgery Center in Fairfax, Virginia. The medical group on file is AllerVie Health. Dmand AI also links Dr. Hamzavi Abedi to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hamzavi Abedi practices. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Hamzavi Abedi's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dmand AI has Dr. Hamzavi Abedi's licenses on file in 2 states: Virginia and New York.

CMS data shows 72 Medicare services from Dr. Hamzavi Abedi across 1 procedure code in 2024, for 50 Medicare patients. Medicare paid $815 for them. Every service was in an office.

CMS counts 50 Medicare patients who saw Dr. Hamzavi Abedi in 2024. The largest group is 65 to 74, with 23 patients. 70% of them have high cholesterol, and 48% have high blood pressure. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hamzavi Abedi's median patient age at 38, with 56% women.

In 2024, Dr. Hamzavi Abedi wrote 28 Medicare Part D claims for 15 patients. 64% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $147 in total drug cost. In 2022, CMS named 23 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Hamzavi Abedi for performance year 2024, reported through an alternative payment model (APM). Dr. Hamzavi Abedi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Hamzavi Abedi. Dr. Hamzavi Abedi has published most often in Allergy Asthma Proc. Dr. Hamzavi Abedi's most frequent co-authors are Maripaz B. Morales, MD and Punita Ponda, MD.

Dmand AI links Dr. Hamzavi Abedi to 1 clinical trial. Conditions studied include Peanut Hypersensitivity and Nut and Peanut Hypersensitivity. Open Payments lists research payments to Dr. Hamzavi Abedi that name 1 trial.

CMS Open Payments shows 69 general payments to Dr. Hamzavi Abedi from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $388. It also lists 5 research payments totaling $1,485 in 2019, naming 1 clinical trial.